Balyasny Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Balyasny Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,381	Closed	-$26K	–	2398
2018 Q1	$26K	Sell	11,381 -3,319	-23%	-$7.77K	﹤0.01%	1875
2017 Q4	$43K	Buy	+14,700	New	+$40.6K	﹤0.01%	2017
2017 Q1	–	Sell	-10,300	Closed	-$18K	–	1916
2016 Q4	$18K	Buy	+10,300	New	+$21K	﹤0.01%	1327
2016 Q1	–	Sell	-37,130	Closed	-$178K	–	1738
2015 Q4	$178K	Sell	37,130 -503,286	-93%	-$2.85M	﹤0.01%	1106
2015 Q3	$3M	Buy	+540,416	New	+$3.99M	0.02%	610

Other funds holding BDSI

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Balyasny Asset Management's BDSI Position: Q2 2018 in Review

Balyasny Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2018, closing a stake of 11,381 shares — an estimated $26K sold.

Balyasny Asset Management first reported a position in BDSI in Q3 2015 and held it in 5 quarters. The position peaked at $3M in Q3 2015. 68 funds tracked by Wall St. Rank hold BDSI as of Q2 2018.

Balyasny Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2018 after selling out during the quarter.
Balyasny Asset Management sold 11,381 BioDelivery Sciences International, Inc. shares in Q2 2018, an estimated $26K.
Balyasny Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2015 and held it in 5 quarters.
Balyasny Asset Management's BioDelivery Sciences International, Inc. position peaked at $3M in Q3 2015.
68 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2018.

Based on Balyasny Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.